Zacks Research Estimates Cardinal Health FY2025 Earnings

Cardinal Health, Inc. (NYSE:CAH) – Equities researchers at Zacks Research boosted their FY2025 earnings estimates for Cardinal Health in a research report issued to clients and investors on Thursday, February 20th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $7.88 per share for the year, up from their previous estimate of $7.75. The consensus estimate for Cardinal Health’s current full-year earnings is $7.95 per share. Zacks Research also issued estimates for Cardinal Health’s Q1 2026 earnings at $2.01 EPS, Q3 2026 earnings at $2.54 EPS, FY2026 earnings at $8.85 EPS, Q1 2027 earnings at $2.15 EPS, Q2 2027 earnings at $2.20 EPS and FY2027 earnings at $9.36 EPS.

CAH has been the topic of several other research reports. Barclays lifted their target price on Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Jefferies Financial Group raised Cardinal Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Citigroup lifted their target price on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. StockNews.com cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Four investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $138.40.

Cardinal Health Price Performance

NYSE:CAH opened at $126.96 on Monday. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The stock’s 50-day moving average is $123.62 and its two-hundred day moving average is $117.33. The stock has a market cap of $30.67 billion, a PE ratio of 23.69, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. Cardinal Health’s payout ratio is currently 37.69%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the business. State Street Corp lifted its holdings in shares of Cardinal Health by 4.6% during the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock worth $1,566,913,000 after buying an additional 627,253 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Cardinal Health by 1.9% during the fourth quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company’s stock worth $691,145,000 after purchasing an additional 109,273 shares during the last quarter. Pacer Advisors Inc. grew its holdings in shares of Cardinal Health by 4.7% during the third quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock worth $474,203,000 after purchasing an additional 191,568 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Cardinal Health by 4.6% during the fourth quarter. Invesco Ltd. now owns 3,182,514 shares of the company’s stock worth $376,396,000 after purchasing an additional 140,368 shares during the last quarter. Finally, Marshall Wace LLP boosted its holdings in Cardinal Health by 154.6% in the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company’s stock valued at $372,756,000 after acquiring an additional 1,913,892 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.